I am truly excited to have the opportunity to join BioCancell's Board of Directors. BC-819 has the potential to be the first of its kind DNA-directed cancer therapy. I look forward to being part of BioCanCell as it is targeting this serious unmet medical need.In BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors
To my knowledge, this is the first study to examine both breast tissue and distant sites of the body for bacterial differences in breast cancer.In Cleveland Clinic researchers find link between bacterial imbalances and breast cancer
If we can target specific pro-cancer bacteria, we may be able to make the environment less hospitable to cancer and enhance existing treatments. Larger studies are needed but this work is a solid first step in better understanding the significant role of bacterial imbalances in breast cancer.In Cleveland Clinic researchers find link between bacterial imbalances and breast cancer